Galexis introduces innovative cooling technology
Demand for refrigerated medicines is ever increasing. To increase capacity and ensure competitiveness, Galexis has been using shock freezers since 2021. Galexis is the first pharmaceutical wholesaler to apply this innovative cooling process, setting new standards in pharmaceutical logistics.
Galexis is continuously optimising and developing its services. «We expect demand for refrigerated products to increase significantly over the next five years,» says Sergej Cadjenovic, project manager for supply chain management at Galexis. Chilled products, which include insulin, vaccines or cancer medicines, already account for a significant proportion of Galexis’ orders.
The refrigerated products are transported in cool boxes, the conditioning of which is time-consuming and uses up a large storage area. In order to reduce the time needed to prepare the cool boxes and thus increase capacity in the long term, Galexis was looking for a suitable solution – and found it in the catering industry with the shock freezer. Galexis is the first pharmaceutical wholesaler to use this innovative cooling process, setting new standards in pharmaceutical logistics.
The shock freezer reduces the time required to condition the cool boxes from 14 to 4 hours. This increases Galexis’ agility and allows it to react more flexibly to the market. In addition, the cooling tunnel, where the boxes were previously conditioned, has been freed up and converted to expand the refrigerated warehouse. The introduction of the new cooling technology, with all its advantages for customers, is an example of the objective of the «Professional» strategic programme: to be the first choice in the provision of logistics services and to offer customers clear added value as a strong partner.